Citation

Maruti S, Desjardins I, Bagge CL, Althoff RR. Prev. Med. 2019; ePub(ePub): ePub.

Affiliation

Department of Psychiatry, University of Vermont Medical Center, Burlington, VT, USA.

Copyright

(Copyright © 2019, Elsevier Publishing)

DOI

10.1016/j.ypmed.2019.105854

PMID

31647957

Abstract

Nationwide, the opioid epidemic continues to have a significant and widespread adverse impact on morbidity and mortality. The number of individuals dying by suicide and unintentional overdose has continued to increase over the past decade, with opioids being involved in a significant proportion of each category of mortality in 2017. Currently, most strategies for decreasing opioid-overdose deaths do not include systematic screening for suicide risk, nor do they address the necessity to customize interventions for those who misuse opioids to decrease near-term suicide risk (defined here as less than 72 h) factors. Improved screening of near-term and chronic suicide risk along with rapid access to treatment is of critical importance to prevent opioid-related deaths by suicide.

Copyright © 2018. Published by Elsevier Inc.

Language: en

Keywords

Opioiod use disorders, OUDs; Substance use disorders, SUDs; Suicide; Suicide assessment; Suicide screening